Increased Frequencies of Circulating IFN-γ-Producing Vδ1(+) and Vδ2(+) γδ T Cells in Patients with Asymptomatic Persistent Hepatitis B Virus Infection

Viral Immunology
M J ConroyD G Doherty

Abstract

Hepatitis B virus (HBV) is a leading cause of liver cirrhosis and hepatocellular carcinoma. The outcome of HBV infection is largely determined by the host immune response, with virus-specific cytotoxic T cells being able to mediate immunity against HBV as well as causing liver pathology. γδ T cells are reported to be depleted in patients with HBV-associated liver disease. However, it is not known if these cells control HBV infection in patients with asymptomatic chronic HBV infection. In this study, the frequencies, phenotypes, and interferon-γ production were examined by circulating γδ T cell subsets in a group of asymptomatic HBV carriers with low viral loads and little evidence of liver disease. It is shown that γδ T cells expressing Vδ1 and Vδ2 T cell receptors and effector-memory phenotypes are found at higher frequencies in these patients compared to controls. Vδ2 T cells from the patients expressed interferon-γ significantly more frequently than Vδ2 T cells from healthy donors in the absence of ex vivo stimulation. These data suggest that effector-memory IFN-γ-producing Vδ2 T cells may contribute to the control of HBV in patients with asymptomatic infection, without mediating liver pathology.

References

May 1, 1990·The Journal of Infectious Diseases·P De PaoliG Santini
May 20, 1999·The Journal of Clinical Investigation·J DéchanetJ F Moreau
Mar 23, 2000·The Journal of Experimental Medicine·F M SpadaM B Brenner
Jan 24, 2002·Journal of Hepatology·Yuji SobaoMasafumi Takiguchi
Apr 18, 2002·Annals of the Rheumatic Diseases·I BankA Ben-Nun
May 25, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yao-Shih HsuYun-Fan Liaw
Aug 14, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jamila IsmailiMichel Goldman
Aug 6, 2003·The Journal of Experimental Medicine·Francesco DieliAlfredo Salerno
Sep 24, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Tony KennaDerek G Doherty
Dec 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lucia ContiSandra Gessani
Mar 2, 2005·Nature Reviews. Immunology·Barbara Rehermann, Michelina Nascimbeni
Jun 4, 2005·Science·Marlène BrandesBernhard Moser
Mar 15, 2006·Gastroenterology·Uchenna H IloejeUNKNOWN Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-In HBV (the REVEAL-HBV) Study Group
Oct 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nadia CaccamoAlfredo Salerno
Oct 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sherri DudalVirginie Lafont
Nov 28, 2007·Annual Review of Pathology·Luca G Guidotti, Francis V Chisari
Dec 22, 2007·Journal of Hepatology·Giovanna FattovichFrancesco Donato
Dec 18, 2008·International Journal of Cancer. Journal International Du Cancer·Nicole SchwinnAnnette Paschen
Dec 2, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yong ZouQin Ning
Apr 11, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Leonhard StrossUlrike Protzer

❮ Previous
Next ❯

Citations

Sep 12, 2015·Journal of Autoimmunity·Derek G Doherty
Apr 19, 2019·PLoS Pathogens·Kyong-Mi ChangUNKNOWN Hepatitis B Research Network (HBRN)

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
density gradient centrifugation
flow cytometry

Software Mentioned

CellQuest
Prism GraphPad

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.